Literature DB >> 19296403

Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus.

C C Mok1, L Y Ho, C H To.   

Abstract

OBJECTIVES: To study the annual incidence and standardized incidence ratio (SIR) of cerebrovascular accident (CVA) in patients with systemic lupus erythematosus (SLE). SUBJECTS AND METHODS: The annual incidence of CVA from 1999 to 2007 in a longitudinal cohort of SLE patients was calculated each year and compared with that of the regional population within the same study period. Age-specific SIRs and outcome of CVA in SLE patients were also studied.
RESULTS: In 2007, there were 490 SLE patients in our cohort. The mean annual incidence of CVA between 1999 and 2007 was 6.45/1000 patients and no obvious trend over time was observed. Of the 20 CVAs in patients with SLE, 18 (90%) were ischaemic stroke whereas two (10%) were haemorrhagic stroke. The mean SIR of all types of CVA in SLE patients was 2.02 [95% confidence interval (CI) 1.30-3.81; p = 0.002]. The SIR of ischaemic stroke decreased with age and the stroke incidence was no longer significantly higher than that of the population in patients aged >or= 60 years. Haemorrhagic stroke occurred mainly in younger SLE patients. The duration of hospitalization and the mortality rate for CVA was non-significantly higher in SLE than in non-SLE patients.
CONCLUSIONS: The incidence of CVA in SLE remained constant over the 8 years between 1999 and 2007. Younger SLE patients are at substantially increased risk of CVA compared to age-matched population. The duration of hospitalization and the mortality rate for CVA are similar in SLE and non-SLE patients.

Entities:  

Mesh:

Year:  2009        PMID: 19296403     DOI: 10.1080/03009740902776927

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  17 in total

1.  Lambl's Excrescences: Association with Cerebrovascular Disease and Pathogenesis.

Authors:  Carlos A Roldan; Oleksandr Schevchuck; Kirsten Tolstrup; Paola C Roldan; Leonardo Macias; Clifford R Qualls; Ernest R Greene; Reyaad Hayek; Gerald A Charlton; Wilmer L Sibbitt
Journal:  Cerebrovasc Dis       Date:  2015-06-02       Impact factor: 2.762

2.  Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus.

Authors:  Laurence S Magder; Michelle Petri
Journal:  Am J Epidemiol       Date:  2012-09-27       Impact factor: 4.897

3.  Endovascular Treatment of Spontaneous Intracranial Internal Carotid Dissection in a Young Patient Affected by Systemic Lupus Erythematosus: A Case Report.

Authors:  Sergio Racchiusa; Marcello Longo; Gianmarco Bernava; Antonio Pitrone; Rosario Papa; Francesca Granata; Giuseppe Centorrino; Sergio Lucio Vinci
Journal:  J Vasc Interv Neurol       Date:  2017-10

4.  Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus.

Authors:  Medha Barbhaiya; Candace H Feldman; Hongshu Guan; Jose A Gómez-Puerta; Michael A Fischer; Daniel H Solomon; Brendan Everett; Karen H Costenbader
Journal:  Arthritis Rheumatol       Date:  2017-08-13       Impact factor: 10.995

Review 5.  Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.

Authors:  Justin C Mason; Peter Libby
Journal:  Eur Heart J       Date:  2014-11-27       Impact factor: 29.983

6.  Systemic Lupus Erythematosus and Increased Prevalence of Atherosclerotic Cardiovascular Disease in Hospitalized Patients.

Authors:  Gregory Katz; Nathaniel R Smilowitz; Ashira Blazer; Robert Clancy; Jill P Buyon; Jeffrey S Berger
Journal:  Mayo Clin Proc       Date:  2019-07-11       Impact factor: 7.616

7.  The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study.

Authors:  J Antonio Aviña-Zubieta; Kateryna Vostretsova; Mary A De Vera; Eric C Sayre; Hyon K Choi
Journal:  Semin Arthritis Rheum       Date:  2015-05-19       Impact factor: 5.532

8.  Venous thromboembolism in southern Chinese patients with systemic lupus erythematosus.

Authors:  Chi Chiu Mok; Ling Yin Ho; Ka Lung Yu; Chi Hung To
Journal:  Clin Rheumatol       Date:  2010-01-26       Impact factor: 2.980

9.  Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Authors:  John G Hanly; Qiuju Li; Li Su; Murray B Urowitz; Caroline Gordon; Sang-Cheol Bae; Juanita Romero-Diaz; Jorge Sanchez-Guerrero; Sasha Bernatsky; Ann E Clarke; Daniel J Wallace; David A Isenberg; Anisur Rahman; Joan T Merrill; Paul Fortin; Dafna D Gladman; Ian N Bruce; Michelle Petri; Ellen M Ginzler; M A Dooley; Kristjan Steinsson; Rosalind Ramsey-Goldman; Asad A Zoma; Susan Manzi; Ola Nived; Andreas Jonsen; Munther A Khamashta; Graciela S Alarcón; Winn Chatham; Ronald F van Vollenhoven; Cynthia Aranow; Meggan Mackay; Guillermo Ruiz-Irastorza; Manuel Ramos-Casals; S Sam Lim; Murat Inanc; Kenneth C Kalunian; Soren Jacobsen; Christine A Peschken; Diane L Kamen; Anca Askanase; Chris Theriault; Vernon Farewell
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-09-01       Impact factor: 4.794

10.  Comparative risks of cardiovascular disease events among SLE patients receiving immunosuppressive medications.

Authors:  May Y Choi; Daniel Li; Candace H Feldman; Kazuki Yoshida; Hongshu Guan; Seoyoung C Kim; Brendan M Everett; Karen H Costenbader
Journal:  Rheumatology (Oxford)       Date:  2021-08-02       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.